An illustration picture shows vials with COVID-19 vaccine stickers attached and syringes with the logo of US pharmaceuticalcompany Pfizer and German partner BioNTech, on November 17, 2020. (Photo: AFP)
December 1, 2020
EU health agency to meet by Dec 29 for Pfizer vaccine decision
BERLIN, Germany (AFP) — The European Medicines Agency (EMA) on Tuesday said it would hold an extraordinary meeting on December 29 “at the latest” to consider emergency approval for a COVID-19 vaccine developed by Germany’s BioNTech and US giant Pfizer.
“If the data submitted are robust enough to conclude on the quality, safety and effectiveness of the vaccine, EMA… will conclude its assessment during an extraordinary meeting scheduled for 29 December at the latest,” the EU regulator said in a statement.
Pfizer and BioNTech earlier announced they had formally applied for conditional EU approval for their jab, following a similar request in the United States.
